SPX4,080.11+122.48 3.09%
DIA346.15+7.67 2.27%
IXIC11,468.00+484.22 4.41%

BTIG Maintains Buy on Mustang Bio, Lowers Price Target to $4

Benzinga · 11/16/2022 07:48
BTIG analyst Justin Zelin maintains Mustang Bio (NASDAQ:MBIO) with a Buy and lowers the price target from $8 to $4.